New Bill could enhance UK clinical trial regulation
European Pharmaceutical Review
OCTOBER 27, 2023
If achieved, this would boost the UK’s competitiveness as a leading international site for trials. This is according to a 2016 paper published in Clinical and Translational Oncology. This activity should bring together relevant data sets which are collected by both the Medicines and Healthcare products Regulatory Agency (MHRA) and HRA.
Let's personalize your content